Guarini A - Search Results

1

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.

Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, Foà R, Santoni A. Soriani A, et al. Among authors: guarini a. Blood. 2009 Apr 9;113(15):3503-11. doi: 10.1182/blood-2008-08-173914. Epub 2008 Dec 19. Blood. 2009. PMID: 19098271 Free article.

2

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

3

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Among authors: guarini a. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

4

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease.

Foa R, Fierro MT, Cesano A, Guarini A, Bonferroni M, Raspadori D, Miniero R, Lauria F, Gavosto F. Foa R, et al. Among authors: guarini a. Blood. 1991 Aug 15;78(4):1041-6. Blood. 1991. PMID: 1868239 Free article.

5

Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Foa R, et al. Among authors: guarini a. Blood. 1990 Jul 15;76(2):393-400. Blood. 1990. PMID: 2114936 Free article.

6

Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.

Foa R, Fierro MT, Raspadori D, Bonferroni M, Cardona S, Guarini A, Tos AG, di Celle PF, Cesano A, Matera L. Foa R, et al. Among authors: guarini a. Blood. 1990 Oct 1;76(7):1349-54. Blood. 1990. PMID: 2207312 Free article.

7

Gene transfer in tumor therapy.

Forni G, Parmiani G, Guarini A, Foà R. Forni G, et al. Among authors: guarini a. Ann Oncol. 1994 Nov;5(9):789-94. doi: 10.1093/oxfordjournals.annonc.a059006. Ann Oncol. 1994. PMID: 7848881 Free article. Review. No abstract available.

8

Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

Meloni G, Foa R, Vignetti M, Guarini A, Fenu S, Tosti S, Tos AG, Mandelli F. Meloni G, et al. Among authors: guarini a. Blood. 1994 Oct 1;84(7):2158-63. Blood. 1994. PMID: 7919330 Free article. Clinical Trial.

9

Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.

Guarini A, Riera L, Cignetti A, Montacchini L, Massaia M, Foa R. Guarini A, et al. Blood. 1997 Jan 1;89(1):212-8. Blood. 1997. PMID: 8978294 Free article.

10

Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.

Vitale A, Guarini A, Latagliata R, Cignetti A, Foa R. Vitale A, et al. Among authors: guarini a. Br J Haematol. 1998 Apr;101(1):150-7. doi: 10.1046/j.1365-2141.1998.00645.x. Br J Haematol. 1998. PMID: 9576195 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters